DAFNA Capital Management LLC Acquires 5,500 Shares of Align Technology, Inc. $ALGN

Key Points

• DAFNA Capital Management LLC increased its stake in Align Technology, Inc. by 100%, acquiring an additional 5,500 shares, bringing its total holdings to 11,000 shares valued at approximately $1.75 million.
• Align Technology's CEO Joseph M. Hogan purchased 7,576 shares at an average cost of $131.49 each, increasing his ownership in the company to 184,945 shares worth over $24 million.
• The company has initiated a $1 billion share repurchase program, indicating that its board believes the stock is undervalued.

DAFNA Capital Management LLC raised its holdings in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 100.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,000 shares of the medical equipment provider's stock after buying an additional 5,500 shares during the quarter. DAFNA Capital Management LLC's holdings in Align Technology were worth $1,747,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Compagnie Lombard Odier SCmA acquired a new stake in shares of Align Technology in the 1st quarter valued at $32,000. Center for Financial Planning Inc. acquired a new stake in shares of Align Technology in the 1st quarter valued at $35,000. SVB Wealth LLC acquired a new stake in shares of Align Technology in the 1st quarter valued at $36,000. Orion Capital Management LLC acquired a new stake in shares of Align Technology in the 4th quarter valued at $42,000. Finally, Mather Group LLC. boosted its stake in shares of Align Technology by 375.0% in the 1st quarter. Mather Group LLC. now owns 437 shares of the medical equipment provider's stock valued at $69,000 after purchasing an additional 345 shares in the last quarter. Institutional investors own 88.43% of the company's stock.

Insider Activity at Align Technology

In related news, CEO Joseph M. Hogan purchased 7,576 shares of the stock in a transaction dated Friday, August 1st. The stock was bought at an average cost of $131.49 per share, with a total value of $996,168.24. Following the purchase, the chief executive officer directly owned 184,945 shares in the company, valued at $24,318,418.05. The trade was a 4.27% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.66% of the stock is currently owned by company insiders.

Align Technology Trading Up 0.6%

Align Technology stock opened at $141.96 on Friday. The company has a market cap of $10.29 billion, a PE ratio of 23.94, a PEG ratio of 1.59 and a beta of 1.61. The company's 50-day moving average is $171.61 and its two-hundred day moving average is $174.56. Align Technology, Inc. has a 1 year low of $127.70 and a 1 year high of $262.87.

Align Technology (NASDAQ:ALGN - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The medical equipment provider reported $2.49 EPS for the quarter, missing analysts' consensus estimates of $2.57 by ($0.08). The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1.06 billion. Align Technology had a net margin of 11.04% and a return on equity of 13.36%. The business's revenue was down 1.6% compared to the same quarter last year. During the same period last year, the company earned $2.41 earnings per share. Align Technology has set its Q3 2025 guidance at EPS. Research analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology announced that its board has initiated a share repurchase program on Tuesday, May 6th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the medical equipment provider to repurchase up to 7.9% of its shares through open market purchases. Shares buyback programs are often an indication that the company's board believes its shares are undervalued.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on ALGN. Stifel Nicolaus reduced their target price on shares of Align Technology from $275.00 to $200.00 and set a "buy" rating on the stock in a research note on Thursday, July 31st. Mizuho set a $210.00 price target on shares of Align Technology in a research report on Thursday, July 31st. Evercore ISI upped their price target on shares of Align Technology from $200.00 to $220.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 9th. Piper Sandler reduced their price target on shares of Align Technology from $250.00 to $190.00 and set an "overweight" rating on the stock in a research report on Thursday, July 31st. Finally, Wells Fargo & Company cut their target price on shares of Align Technology from $246.00 to $199.00 and set an "overweight" rating on the stock in a research report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $215.00.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.